BiosanaPharma

BiosanaPharma is a biotechnology company operating in Australia, the Netherlands, and Singapore. Its mission is to make monoclonal antibody therapies more affordable and accessible to patients through intelligent, disruptive technologies. The company aims to enhance affordability by utilizing its proprietary 3C process. It is building a unique and highly competitive portfolio of monoclonal antibodies and biosimilar products.